Memspatch

Memspatch
Product Description

A Proprietary micro-injector system for delivering liquid injectables through the skin to different controlled depths. This technology has been developed in conjunction with reformulations of Sumatriptan for Migraine, and Fentanyl for BTP, amongst a number of other small and large molecules currently in development with planned Regulatory submissions within 1-2 years. 

Nemaura Pharma Limited

  • GB
  • 2017
    On CPHI since
Specifications
  • Selling Points
    International Approvals/Standards; Quality Service
  • Supplied from
    United Kingdom

Nemaura Pharma Limited

  • GB
  • 2017
    On CPHI since

More Products from Nemaura Pharma Limited (2)

  • Micropatch

    Product Micropatch

    A proprietary injector system that allows solid particles or drug coatings on needles to be instantly released into the skin using a low cost disposable applicator. Drugs such as Teriparatide and some vaccines are currently in development using this technology platform. 
  • Transdermal Patch

    Product Transdermal Patch

    We have successfully developed a number of transdermal patches for indications including Alzheimer's, Parkinsons, and Hypertension and offer an end to end solution for licensees for old and new drugs intended for delivery through transdermal patches.